Cargando…
Serotonin: A mediator of the gut–brain axis in multiple sclerosis
BACKGROUND: The significance of the gut microbiome for the pathogenesis of multiple sclerosis (MS) has been established, although the underlying signaling mechanisms of this interaction have not been sufficiently explored. OBJECTIVES: We address this point and use serotonin (5-hydroxytryptamine (5-H...
Autores principales: | Malinova, Tsveta S, Dijkstra, Christine D, de Vries, Helga E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052430/ https://www.ncbi.nlm.nih.gov/pubmed/29117778 http://dx.doi.org/10.1177/1352458517739975 |
Ejemplares similares
-
Recommendations for cognitive screening and management in multiple sclerosis care
por: Kalb, Rosalind, et al.
Publicado: (2018) -
Recommendations for the use of propensity score methods in multiple
sclerosis research
por: Simoneau, Gabrielle, et al.
Publicado: (2022) -
Pathways to cures for multiple sclerosis: A research roadmap
por: Bebo, Bruce F, et al.
Publicado: (2022) -
COVID-19 in people with multiple sclerosis: A global data sharing initiative
por: Peeters, Liesbet M, et al.
Publicado: (2020) -
Ethical use of off-label disease-modifying therapies for multiple sclerosis
por: Laurson-Doube, Joanna, et al.
Publicado: (2021)